PortfoliosLab logo

Allogene Therapeutics, Inc. (ALLO)

Equity · Currency in USD · Last updated Jan 28, 2023

Company Info

ISINUS0197701065
CUSIP019770106
SectorHealthcare
IndustryBiotechnology

Trading Data

Previous Close$7.92
Year Range$5.62 - $17.28
EMA (50)$7.72
EMA (200)$9.58
Average Volume$2.02M
Market Capitalization$1.13B

ALLOShare Price Chart


Loading data...

ALLOPerformance

The chart shows the growth of $10,000 invested in Allogene Therapeutics, Inc. in Aug 2022 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $3,168 for a total return of roughly -68.32%. All prices are adjusted for splits and dividends.


-60.00%-40.00%-20.00%0.00%20.00%40.00%SeptemberOctoberNovemberDecember2023
-36.69%
-0.51%
ALLO (Allogene Therapeutics, Inc.)
Benchmark (^GSPC)

ALLOCompare to other instruments

Search for stocks, ETFs, and funds to compare with ALLO

Allogene Therapeutics, Inc.

ALLOReturns in periods

Returns over 1 year are annualized

PeriodReturnBenchmark
YTD25.91%6.02%
1M40.93%6.30%
6M-40.23%-0.05%
1Y-29.41%-6.42%
5Y-23.53%9.78%
10Y-23.53%9.78%

ALLOMonthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
202213.86%5.62%-21.23%-4.63%-4.27%-36.21%

ALLOSharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Allogene Therapeutics, Inc. Sharpe ratio is -0.38. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.


-0.80-0.60-0.40-0.20SeptemberOctoberNovemberDecember2023
-0.38
-0.27
ALLO (Allogene Therapeutics, Inc.)
Benchmark (^GSPC)

ALLODividend History


Allogene Therapeutics, Inc. doesn't pay dividends

ALLODrawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-80.00%-60.00%-40.00%-20.00%SeptemberOctoberNovemberDecember2023
-85.34%
-15.14%
ALLO (Allogene Therapeutics, Inc.)
Benchmark (^GSPC)

ALLOWorst Drawdowns

The table below shows the maximum drawdowns of the Allogene Therapeutics, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Allogene Therapeutics, Inc. is 89.60%, recorded on Dec 27, 2022. The portfolio has not recovered from it yet.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-89.6%May 26, 2020654Dec 27, 2022
-45.29%Nov 7, 2018341Mar 18, 202037May 11, 2020378
-16.54%Oct 16, 20187Oct 24, 20187Nov 2, 201814
-7.25%May 12, 20202May 13, 20201May 14, 20203
-0.39%May 19, 20201May 19, 20201May 20, 20202

ALLOVolatility Chart

Current Allogene Therapeutics, Inc. volatility is 95.89%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.


20.00%40.00%60.00%80.00%100.00%SeptemberOctoberNovemberDecember2023
95.89%
16.76%
ALLO (Allogene Therapeutics, Inc.)
Benchmark (^GSPC)